MEDIUM confidence: 100% data completeness, but the composite (57) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Net insider -$14.3M over 180 days (0 open-market buys, 15 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 57 for CRS indicates a moderately favorable outlook, driven by strong growth and momentum scores of 61 and 77, respectively. The stock's high revenue and earnings growth rates, as well as its significant 12-month return of 124.2%, contribute to its positive assessment. However, its value score of 29 is a notable detractor, due to a high P/E of 61.8 and P/B of 14.3, indicating the stock trades at a premium. The short-term score of 63 diverges from the long-term score of 51, suggesting recent performance has been particularly strong.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.5B— | $1.8B+24.4% | $2.6B+38.9% | $2.8B+8.2% | $2.9B+4.3% |
| EPS (dil.) | $-4.75— | $-1.01n/m | $1.14n/m | $3.70+224.6% | $7.42+100.5% |
| Free Cash Flow | $150M— | -$85M-157.1% | -$68Mn/m | $178Mn/m | $286M+60.5% |
| Gross Margin | 0.1% | 8.2%+8.1pp | 13.2%+5.1pp | 21.2%+7.9pp | 26.7%+5.5pp |
| Operating Margin | -16.8% | -1.4%+15.5pp | 5.2%+6.6pp | 11.7%+6.5pp | 18.1%+6.4pp |
| Net Margin | -15.6% | -2.7%+12.9pp | 2.2%+4.9pp | 6.8%+4.5pp | 13.1%+6.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $464 (last qtr, 6 analysts) → $0 (last mo, 0) (-100.0%).
Buy-rated share 89% → 89% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Apr 2026 | $2.63 | $2.77 | +5.3% |
| Jan 2026 | $2.22 | $2.33 | +5.0% |
| Oct 2025 | $2.13 | $2.43 | +14.1% |
| Jul 2025 | $2.07 | $2.21 | +6.8% |
| Apr 2025 | $1.74 | $1.88 | +8.0% |
| Jan 2025 | $1.56 | $1.66 | +6.4% |
| Oct 2024 | $1.58 | $1.73 | +9.5% |
| Jul 2024 | $1.51 | $1.82 | +20.5% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.